OncoMatch/Clinical Trials/NCT06237179
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Is NCT06237179 recruiting? Yes, currently enrolling (Jun 2026). This Phase 1/2 trial studies non-drug interventions for prostate cancer.
To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak \& 6-minute walk distance \[6MWD\]) among prostate cancer (PC) patients compared to controls receiving healthy living education (HLE) at 12 weeks.
Check if I qualifyExtracted eligibility criteria
Cancer type
Prostate Cancer
Disease stage
Required: Stage II, III, IV
Demographics
Prior therapy
Must have received: androgen deprivation therapy — current
currently undergoing treatment with ADT (intermittent or prolonged)
Must have received: local curative-intent treatment (prostatectomy, definitive radiation) — completed
completed local curative-intent treatment, including prostatectomy or definitive radiation
Lab requirements
Blood counts
Hemoglobin < 7.0 grams/dL and Platelet count < 10 x 10^9/L excluded
Hemoglobin < 7.0 grams/dL; Platelet count < 10 x 109/L
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Richmond Veterans Affairs Medical Center · Richmond, Virginia
- Virginia Commonwealth University Massey Cancer Center · Richmond, Virginia
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT06237179 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received androgen deprivation therapy and local curative-intent treatment.
What disease stage is eligible?
Stage II or III or IV is required.
Is there an age limit?
Yes. Patients must be 85 years or younger and at least 40 years old.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages